Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 45 articles:
HTML format
Text format



Single Articles


    November 2017
  1. PIEL C, Pouchieu C, Tual S, Migault L, et al
    Central nervous system tumors and agricultural exposures in the prospective cohort AGRICAN.
    Int J Cancer. 2017;141:1771-1782.
    PubMed     Text format     Abstract available


    October 2017
  2. SRIVASTAVA C, Irshad K, Dikshit B, Chattopadhyay P, et al
    FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Int J Cancer. 2017 Oct 9. doi: 10.1002/ijc.31092.
    PubMed     Text format     Abstract available


  3. GE H, Mu L, Jin L, Yang C, et al
    Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
    Int J Cancer. 2017;141:1434-1444.
    PubMed     Text format     Abstract available


    September 2017
  4. VIDART D'EGURBIDE BAGAZGOITIA , Bailey HD, Orsi L, Lacour B, et al
    Maternal residential pesticide use during pregnancy and risk of malignant childhood brain tumors: A pooled analysis of the ESCALE and ESTELLE studies (SFCE).
    Int J Cancer. 2017 Sep 26. doi: 10.1002/ijc.31073.
    PubMed     Text format     Abstract available


  5. CIAGLIA E, Laezza C, Abate M, Pisanti S, et al
    Recognition by Natural Killer cells of N6 -isopentenyladenosine-treated human glioma cell lines.
    Int J Cancer. 2017 Sep 7. doi: 10.1002/ijc.31036.
    PubMed     Text format     Abstract available


    August 2017
  6. ESAKI S, Nigim F, Moon E, Luk S, et al
    Blockade of transforming growth factor-beta signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
    Int J Cancer. 2017 Aug 12. doi: 10.1002/ijc.30929.
    PubMed     Text format     Abstract available


    July 2017
  7. YANG J, Liu R, Deng Y, Qian J, et al
    MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR.
    Int J Cancer. 2017 Jul 31. doi: 10.1002/ijc.30912.
    PubMed     Text format     Abstract available


  8. BAYSAN M, Woolard K, Cam MC, Zhang W, et al
    Detailed Longitudinal Sampling of Glioma Stem Cells In Situ Reveals Chr7 Gain and Chr10 Loss As Repeated Events in Primary Tumor Formation and Recurrence.
    Int J Cancer. 2017 Jul 14. doi: 10.1002/ijc.30887.
    PubMed     Text format     Abstract available


  9. DEJAEGHER J, Verschuere T, Vercalsteren E, Boon L, et al
    Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade.
    Int J Cancer. 2017 Jul 6. doi: 10.1002/ijc.30877.
    PubMed     Text format     Abstract available


    May 2017
  10. JAHAN N, Lee JM, Shah K, Wakimoto H, et al
    Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30811.
    PubMed     Text format     Abstract available


    April 2017
  11. PEVERELLI E, Giardino E, Treppiedi D, Meregalli M, et al
    Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors.
    Int J Cancer. 2017;140:1870-1880.
    PubMed     Text format     Abstract available


    March 2017
  12. QIAN Z, Ren L, Wu D, Yang X, et al
    Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
    Int J Cancer. 2017 Mar 14. doi: 10.1002/ijc.30690.
    PubMed     Text format     Abstract available


    February 2017
  13. CIAGLIA E, Abate M, Laezza C, Pisanti S, et al
    Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.
    Int J Cancer. 2017;140:959-972.
    PubMed     Text format     Abstract available


    January 2017
  14. BAILEY HD, Rios P, Lacour B, Guerrini-Rousseau L, et al
    Factors related to pregnancy and birth and the risk of childhood brain tumours: The ESTELLE and ESCALE studies (SFCE, France).
    Int J Cancer. 2017 Jan 5. doi: 10.1002/ijc.30597.
    PubMed     Text format     Abstract available


    September 2016
  15. WANG J, Voellger B, Benzel J, Schlomann U, et al
    Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
    Int J Cancer. 2016;139:1327-39.
    PubMed     Text format     Abstract available


    August 2016
  16. OGAWA T, Sawada N, Iwasaki M, Budhathoki S, et al
    Coffee and green tea consumption in relation to brain tumor risk in a Japanese population.
    Int J Cancer. 2016 Aug 25. doi: 10.1002/ijc.30405.
    PubMed     Text format     Abstract available


  17. MUKHERJEE S, Baidoo J, Fried A, Atwi D, et al
    Curcumin Changes the Polarity of Tumor-Associated Microglia and Eliminates Glioblastoma.
    Int J Cancer. 2016 Aug 20. doi: 10.1002/ijc.30398.
    PubMed     Text format     Abstract available


  18. MADAN E, Dikshit B, Gowda SH, Srivastava C, et al
    FAT1 is a novel upstream regulator of HIF1alpha and invasion of high grade glioma.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30386.
    PubMed     Text format     Abstract available


    July 2016
  19. DARLIX A, Lamy PJ, Lopez-Crapez E, Braccini AL, et al
    Serum NSE, MMP-9 and HER2 extra-cellular domain are associated with brain metastases in metastatic breast cancer patients: Predictive biomarkers for brain metastases?
    Int J Cancer. 2016 Jul 27. doi: 10.1002/ijc.30290.
    PubMed     Text format     Abstract available


  20. KAHLERT UD, Mooney SM, Natsumeda M, Steiger HJ, et al
    Targeting Cancer Stem-like Cells in Glioblastoma and Colorectal Cancer through Metabolic Pathways.
    Int J Cancer. 2016 Jul 8. doi: 10.1002/ijc.30259.
    PubMed     Text format     Abstract available


  21. BERENGUER-DAIZE C, Astorgues-Xerri L, Odore E, Cayol M, et al
    OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models.
    Int J Cancer. 2016 Jul 7. doi: 10.1002/ijc.30256.
    PubMed     Text format     Abstract available


    June 2016
  22. MAXWELL R, Garzon-Muvdi T, Lipson EJ, Sharfman WH, et al
    BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis.
    Int J Cancer. 2016 Jun 25. doi: 10.1002/ijc.30241.
    PubMed     Text format     Abstract available


  23. ERNST A, Jones DT, Maass KK, Rode A, et al
    Telomere dysfunction and chromothripsis.
    Int J Cancer. 2016;138:2905-14.
    PubMed     Text format     Abstract available


  24. PHILLIPS E, Lang V, Bohlen J, Bethke F, et al
    Targeting Atypical Protein Kinase C iota Reduces Viability in Glioblastoma Stem-like cells via a Notch Signaling Mechanism.
    Int J Cancer. 2016 Jun 14. doi: 10.1002/ijc.30234.
    PubMed     Text format     Abstract available


    May 2016
  25. OJI Y, Hashimoto N, Tsuboi A, Murakami Y, et al
    Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide.
    Int J Cancer. 2016 May 11. doi: 10.1002/ijc.30182.
    PubMed     Text format     Abstract available


    April 2016
  26. SMALLEY KS, Fedorenko IV, Kenchappa R, Sahebjam S, et al
    Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.
    Int J Cancer. 2016 Apr 15. doi: 10.1002/ijc.30147.
    PubMed     Text format     Abstract available


    March 2016
  27. MOCK A, Geisenberger C, Orlik C, Warta R, et al
    LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients.
    Int J Cancer. 2016 Mar 2. doi: 10.1002/ijc.30069.
    PubMed     Text format     Abstract available


    February 2016
  28. BATISTA R, Cruvinel-Carloni A, Vinagre J, Peixoto J, et al
    The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
    Int J Cancer. 2016 Feb 23. doi: 10.1002/ijc.30057.
    PubMed     Text format     Abstract available


  29. MUKHERJEE J, Ohba S, See WL, Phillips JJ, et al
    PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells.
    Int J Cancer. 2016 Feb 13. doi: 10.1002/ijc.30041.
    PubMed     Text format     Abstract available


    November 2015
  30. ZHOU N, Yao Y, Ye H, Zhu W, et al
    Abscisic acid-induced cellular apoptosis and differentiation in glioma via the retinoid acid signaling pathway.
    Int J Cancer. 2015 Nov 23. doi: 10.1002/ijc.29935.
    PubMed     Text format     Abstract available


    October 2015
  31. SCHNEIDER M, Strobele S, Nonnenmacher L, Siegelin MD, et al
    A paired comparison between glioblastoma 'stem cells' and differentiated cells.
    Int J Cancer. 2015 Oct 30. doi: 10.1002/ijc.29908.
    PubMed     Text format     Abstract available


  32. BEAUCHESNE P, Quillien V, Faure G, Bernier V, et al
    A concurrent ultra-fractionated radiation therapy and temozolomide treatment; a promising therapy for newly diagnosed, inoperable glioblastoma.
    Int J Cancer. 2015 Oct 26. doi: 10.1002/ijc.29898.
    PubMed     Text format     Abstract available


    September 2015
  33. KAHLERT UD, Cheng M, Koch K, Marchionni L, et al
    Alterations in Cellular Metabolome after Pharmacological Inhibition of Notch in Glioblastoma Cells.
    Int J Cancer. 2015 Sep 30. doi: 10.1002/ijc.29873.
    PubMed     Text format     Abstract available


  34. ALBRECHT V, Richter A, Pfeiffer S, Gebauer M, et al
    Anticalins directed against the fibronectin extra domain B (ED-B) as diagnostic tracers for glioblastomas.
    Int J Cancer. 2015 Sep 30. doi: 10.1002/ijc.29874.
    PubMed     Text format     Abstract available



  35. Erratum: Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.
    Int J Cancer. 2015;137:E10-E11.
    PubMed     Text format    


    August 2015
  36. AMAYIRI N, Tabori U, Campbell B, Bakry D, et al
    High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan.
    Int J Cancer. 2015 Aug 8. doi: 10.1002/ijc.29724.
    PubMed     Text format     Abstract available


  37. BHATTI P, Doody DR, Mckean-Cowdin R, Mueller BA, et al
    Response to "importance of C-3 epimer of 25-hydroxyvitamin D in dried blood spots of neonatal population".
    Int J Cancer. 2015;137:751.
    PubMed     Text format    


  38. TAPAN S, Sertoglu E, Uyanik M
    Importance of C-3 epimer of 25-hydroxyvitamin D in dried blood spots of neonatal population.
    Int J Cancer. 2015;137:750.
    PubMed     Text format    


  39. DODGSHUN AJ, Maixner WJ, Heath JA, Sullivan MJ, et al
    Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multi-agent chemotherapy.
    Int J Cancer. 2015 Aug 1. doi: 10.1002/ijc.29711.
    PubMed     Text format     Abstract available


    July 2015
  40. MATHIOS D, Park CK, Marcus WD, Alter S, et al
    Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model.
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29686.
    PubMed     Text format     Abstract available


    June 2015
  41. BOUCHET A, Sakakini N, Atifi ME, Le Clec'h C, et al
    Identification of AREG and PLK1 pathway modulation as a potential key of the response of intracranial 9L tumor to microbeam radiation therapy.
    Int J Cancer. 2015;136:2705-16.
    PubMed     Text format     Abstract available


    May 2015
  42. YANG CM, Chiba T, Brill B, Delis N, et al
    Expression of the miR-302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes.
    Int J Cancer. 2015 May 20. doi: 10.1002/ijc.29606.
    PubMed     Text format     Abstract available


  43. JHA P, Agrawal R, Pathak P, Kumar A, et al
    Genome-wide small noncoding RNA profiling of pediatric high grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52, and delineates H3F3A and TP53 mutant specific miRNAs and snoRNAs.
    Int J Cancer. 2015 May 20. doi: 10.1002/ijc.29610.
    PubMed     Text format     Abstract available


    October 2014
  44. BENSON VS, Kirichek O, Beral V, Green J, et al
    Menopausal hormone therapy and central nervous system tumor risk: Large UK prospective study and meta-analysis.
    Int J Cancer. 2014 Oct 21. doi: 10.1002/ijc.29274.
    PubMed     Text format     Abstract available


  45. OSELLA-ABATE S, Ribero S, Sanlorenzo M, Maule MM, et al
    Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years.
    Int J Cancer. 2014 Oct 21. doi: 10.1002/ijc.29281.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: